ArticlePLoS neglected tropical diseases2026
Evaluation of the autonomic nervous system in autochthonous patients from Amazon with acute Chagas disease treated with benznidazole.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chagas disease, a neglected tropical disease, is endemic in the Amazon region, where oral transmission predominates. Autonomic nervous system (ANS) impairment is a recognized pathophysiological mechanism contributing to disease progression, including Chagas cardiomyopathy. This study aimed to assess ANS function in patients with acute Chagas disease from the Amazon, evaluating responses pre- and post-benznidazole treatment. We included 28 acute-phase patients and 20 healthy controls. Participants underwent comprehensive cardiac evaluations, including 12-lead ECG, echocardiogram, 24-hour Holter monitoring, treadmill stress testing, and 5-minute heart rate variability (HRV) assessment. HRV was analyzed across time, frequency, and nonlinear domains, with statistical comparisons performed between groups and within the patient cohort. The study population predominantly comprised individuals from rural Amazonian municipalities (89.3%), with oral transmission accounting for 85.7% of infections. While resting ECGs were normal in 60.7%, diffuse ventricular repolarization was the most common abnormality (21.4%). Before treatment, 24-hour HRV showed significant reductions in SDANN and SDNN, indicating sympathovagal imbalance. For 5-minute HRV, significant alterations were observed across time (rMSSD, SDNN), frequency (LF, HF, LF/HF ratio), and nonlinear domains, reflecting reduced parasympathetic tone. Intragroup comparisons (pre- vs. post-treatment) further reinforced the sustained sympathovagal imbalance and parasympathetic inhibition. These findings highlight persistent autonomic modulation alterations, characterized by sympathovagal imbalance and reduced parasympathetic activity, in acute Chagas disease patients from the Amazon. Such dysfunction may predispose individuals to long-term structural cardiac changes and arrhythmias, underscoring the critical need for continued monitoring and potential targeted interventions to address autonomic imbalance in this vulnerable population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.